DelveInsight’s "Fabry Disease - Epidemiology Forecast, 2027” report provides a comprehensive analysis of the Fabry Disease epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 2016-2027.
Markets Covered • United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan
Study Period: 2016-2027
Fabry Disease Epidemiology The epidemiology section covers the historical, current as well as forecasted epidemiology for Fabry Disease in 7 major markets. The data is collected by understanding the disease, reviewing numerous studies conducted by countries and by exploring different surveys as well as reports. The Key opinion leaders’ views are also taken into account to provide a deep understanding of the Fabry Disease outlook. It also includes the explanation of changing trends of epidemiology outlining the Fabry Disease scenario.
Fabry Disease Epidemiology Segmentation The epidemiology section is further segmented according to the patient pool characteristics, such as age-specific, type-specific, sub-type specific, gender-specific etc., thus providing an in-depth and high-quality analysis. The report also covers the prevalent/Incidence cases as well as the treatable cases as per the therapies available for the Fabry Disease thereby presenting the trends with detailed analysis, with the assumptions undertaken. The data is presented in the form of graphs along with tables to effectively summarize the landscape.
Report Scope • The report covers detailed overview of Fabry Disease explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns • It provides the insight about the historical and forecasted patient pool for 7 major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan • The Fabry Disease Report assesses the disease risk and burden and highlights the unmet needs • It also helps to recognize the growth opportunities in the 7MM with respect to the patient population
Key strengths • 10 Year Forecast • 7MM Coverage • Total Cases in Fabry Disease
Key assessments • Patient Segmentation in Fabry Disease • Fabry Disease Risk & Burden • Factors driving growth in a specific Fabry Disease patient population
Our reports have been used by over 10K customers, including:
Pompe Disease: Epidemiology Forecast to 2027 Summary Pompe disease is a rare multisystem disorder caused by pathogenic variations in the GAA gene, which contains the information for production and function of a protein called acid alpha-glucosidase (GAA).Because of the shortage of this protein (an...
Serine Protein Kinase ATM (Ataxia Telangiectasia Mutated or ATM or EC 184.108.40.206) - Pipeline Review, H2 2018 Summary Serine Protein Kinase ATM (Ataxia Telangiectasia Mutated or ATM or EC 220.127.116.11) pipeline Target constitutes close to 7 molecules. Out of which approximately 6 molecules are developed...
Macrophage Migration Inhibitory Factor (Glycosylation Inhibiting Factor or L Dopachrome Isomerase or L Dopachrome Tautomerase or Phenylpyruvate Tautomerase or MIF or EC 18.104.22.168 or EC 22.214.171.124) - Pipeline Review, H2 2018 Summary According to the recently published report ’Macrophage Migration Inhibitory...
India Neurology Devices Market Outlook to 2025 - Hydrocephalus Shunts, Interventional Neuroradiology Devices, Neurosurgical Products and Others Summary GlobalData’s new report, India Neurology Devices Market Outlook to 2025, provides key market data on the India Neurology Devices market. The report...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.